http://www.unboundmedicine.com/medline/ebm/research/cytarabineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19890398/full_citation/Oncogenic_RAS_Enables_DNA_Damage__and_p53_Dependent_Differentiation_of_Acute_Myeloid_Leukemia_Cells_in_Response_to_Chemotherapy_Meyer M, Rübsamen D, Slany R, et al. 
Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy. [Journal Article]
PLoS One 2009; 4(11):e7768.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19889622/full_citation/Salvage_chemotherapy_with_alternating_MINE_ESHAP_regimen_in_relapsed_or_refractory_Hodgkin's_lymphoma_followed_by_autologous_stem_cell_transplantation_Fernández de Larrea C, Martínez C, Gaya A, et al. 
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884541/full_citation/Comparison_of_Neurocognitive_Functioning_in_Children_Previously_Randomly_Assigned_to_Intrathecal_Methotrexate_Compared_With_Triple_Intrathecal_Therapy_for_the_Treatment_of_Childhood_Acute_Lymphoblastic_Leukemia_Kadan-Lottick NS, Brouwers P, Breiger D, et al. 
Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic Leukemia. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19883017/full_citation/["Squalenoylation":_a_new_approach_to_the_design_of_anticancer_and_antiviral_nanomedicines]Couvreur P 
["Squalenoylation": a new approach to the design of anticancer and antiviral nanomedicines] [English Abstract, Journal Article]
Bull Acad Natl Med 2009 Mar; 193(3):663-73; discussion 673-4.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19877831/full_citation/Microencapsulation_of_cytarabine_using_poly_ethylene_glycol__poly_epsilon_caprolactone__diblock_copolymers_as_surfactant_agents_Diab R, Hamoudeh M, Boyron O, et al. 
Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents. [JOURNAL ARTICLE]
Drug Dev Ind Pharm 2009 Oct 30.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19876600/full_citation/Intrathecal_liposomal_cytarabine_in_combination_with_temozolomide_in_low_grade_oligoastrocytoma_with_leptomeningeal_dissemination_Passarin MG, Moretto G, Musso AM, et al. 
Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination. [JOURNAL ARTICLE]
J Neurooncol 2009 Oct 31.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19862526/full_citation/Synergistic_activity_of_nilotinib_and_established_chemotherapeutic_drugs_in_imatinib_sensitive_and__resistant_BCR_ABL_positive_cells_Radujkovic A, Fruehauf S, Zeller WJ, et al. 
Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2009 Oct 28.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19860628/full_citation/Mitoxantrone_and_etoposide_in_patients_with_newly_diagnosed_acute_myeloid_leukemia_with_persistent_leukemia_after_a_course_of_therapy_with_cytarabine_and_idarubicin_McHayleh W, Sehgal R, Redner RL, et al. 
Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin. [JOURNAL ARTICLE]
Leuk Lymphoma 2009 Oct 8.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19852511/full_citation/Targeted_Delivery_of_Antisense_Oligodeoxynucleotide_by_Transferrin_Conjugated_pH_Sensitive_Lipopolyplex_Nanoparticles:_A_Novel_Oligonucleotide__Based_Therapeutic_Strategy_in_Acute_Myeloid_Leukemia_Jin Y, Liu S, Yu B, et al. 
Targeted Delivery of Antisense Oligodeoxynucleotide by Transferrin Conjugated pH-Sensitive Lipopolyplex Nanoparticles: A Novel Oligonucleotide -Based Therapeutic Strategy in Acute Myeloid Leukemia. [JOURNAL ARTICLE]
Mol Pharm 2009 Oct 23.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19846953/full_citation/Rapid_Induction_of_P_Glycoprotein_mRNA_and_Protein_Expression_by_Cytarabine_in_HL_60_Cells_Prenkert M, Uggla B, Tina E, et al. 
Rapid Induction of P-Glycoprotein mRNA and Protein Expression by Cytarabine in HL-60 Cells. [Journal Article]
Anticancer Res 2009 Oct; 29(10):4071-6.
Abstract | Full Citation